Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy - Top-Institutions - MDSpire

Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy

  • By

  • Weitao Yan

  • Wenxuan Lu

  • Ying Dai

  • Xiangchao Meng

  • Kai Feng

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    institutional review board
    institutional review board

    N/A, N/A

    Key Differentiators

    • Ethics Review

  • #2

    Heidelberg University Medical Faculty
    Heidelberg University Medical Faculty

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Medical Ethics

  • #3

    Maastricht University Medical Centre+
    Maastricht University Medical Centre+

    Maastricht, Limburg

    Key Differentiators

    • Medical Research

  • #4

    Kyung Hee University Hospital
    Kyung Hee University Hospital

    Seoul, Seoul

    Key Differentiators

    • Medical Ethics

Original Source(s)

Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy

  • by Weitao Yan, Wenxuan Lu, Ying Dai, Xiangchao Meng, Kai Feng

  • July 10, 2026

Related Content

Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis

Radiomics analysis of biplanar ultrasound images can discriminate non-mass breast carcinoma from mastitis

Influence of age, body mass index and family income on the health Quality of Life among the breast cancer patients in Bangladesh: a cross-sectional study